Investor profile for Atlas Venture: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Atlas Venture stages, portfolio and investment profile

Cambridge, MA–based biotech venture firm that creates and builds early-stage life-sciences companies, partnering with scientists from company formation through Series A.

Keep track of Atlas Venture

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Seed, Series A

Participates: Seed, Series A

Sector focus

Biotech & Life Sciences

Geography

Cambridge, MA

Founded 1980

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Seed Series A

Rounds they invest

Seed Series A

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Related investment articles

FAQs about Atlas Venture

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

Atlas leads Seed and Series A rounds in biotech. The firm is known for company creation — incubating startups internally before or alongside first institutional financings.
Atlas does not publish a standard check-size range. As a biotech company-builder, initial financings are sized to hit defined R&D milestones rather than a fixed ticket.
Headquartered in Cambridge, MA, in the heart of the Boston/Cambridge biotech cluster. Atlas primarily backs U.S. life-sciences startups, often tied to regional research institutions.
Atlas focuses exclusively on biotechnology and life sciences — therapeutics, platform biology, and related modalities — through a science-first, company-formation model.
Atlas typically leads seed and Series A rounds in companies it helps found or incubate. It is an active board-level partner, not a passive follower.
We do not yet have portfolio companies linked to Atlas Venture in our directory. Atlas’s public portfolio is listed at atlasventure.com.
Atlas engages entrepreneurial scientists and repeat biotech operators — often before a company is fully formed. Introductions through scientific networks, prior Atlas entrepreneurs, or co-investors in the Boston biotech ecosystem are the practical path.
No dedicated Atlas article in our blog yet. See the fund profile at /fund/atlas-venture.

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.